EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

Timing‐dependent protective and therapeutic effects of ethyl pyruvate in trinitrobenzene sulfonic acid‐induced experimental colitis

Hatice Yorulmaz iD, Elif Yorulmaz iD, Elif Özkök iD, Suat Hayri Küçük iD, Erdem Sünger iD, Ayyub Ebrahimi iD, Beyza Yılmaz iD, Serdar Altınay iD

Experimental Physiology · 2026-08 · 111 (8) · 3731-3741

DOI: 10.1113/ep093786 ↗

At a glance

Journal article in Experimental Physiology, published online on 2026-06-17. Written by Hatice Yorulmaz and 7 co-authors. Institution: Faculty of Medicine, Haliç University, Eyup, Istanbul, Turkey. Major MEDLINE topics: Pyruvates, Colitis, Colitis, Ulcerative. 31 references. The full text is freely available (open access, CC BY 4.0). Funded by: Turkish Ministry of Health, Bağcılar Training and Research Hospital.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Ulcerative colitis (UC) involves excessive inflammation, extracellular matrix remodelling and oxidative stress. Ethyl pyruvate (EP) exhibits anti‐inflammatory effects, but the comparative efficacy of prophylactic versus therapeutic administration and timing‐dependent molecular responses remains unclear. The objective of this work was to evaluate timing‐dependent protective and therapeutic effects of EP in trinitrobenzene sulfonic acid (TNBS)‐induced experimental colitis, focusing on inflammatory mediators, matrix metalloproteinases (MMPs), oxidative status and gene expression. Rats were randomly assigned to Control, EP, Colitis, Pre‐colitis (EP before TNBS) and Post‐colitis (EP after TNBS) groups. Colonic injury was assessed macroscopically and histopathologically. Tissue levels of matrix metalloproteinase (MMP)‐2, MMP‐9, interleukin (IL)‐1, IL‐17, IL‐10, nuclear factor‐κB (NF‐κB), inducible nitric oxide synthase (iNOS) and total antioxidant capacity (TAC) were measured using ELISA kits. Gene expression of MMP‐9, cytokines, NF‐κB, high mobility group box 1 (HMGB1), iNOS and interferon‐γ was analysed by quantitative real‐time PCR. TNBS induced severe colonic injury with upregulation of pro‐inflammatory cytokines, NF‐κB signalling, MMP‐2/9 and oxidative imbalance ( P < 0.01). EP attenuated tissue damage in both prophylactic and therapeutic settings. Post‐colitis (therapeutic) EP administration produced greater suppression of MMP‐2, MMP‐9, NF‐κB, HMGB1 and iNOS, along with superior restoration of TAC ( P < 0.05), indicating timing‐dependent modulation of inflammatory and matrix degradation pathways. EP exerts both preventive and therapeutic effects in TNBS‐induced colitis by suppressing inflammatory signalling, regulating extracellular matrix remodelling and enhancing antioxidant defences. Therapeutic administration is more effective than prophylactic treatment, highlighting the importance of timing in optimizing EP's efficacy in inflammatory bowel disease.

Subjects

MeSH terms (MEDLINE)

PyruvatesColitisColitis, UlcerativeAnimalsTrinitrobenzenesulfonic AcidMaleOxidative StressNitric Oxide Synthase Type IIColonMatrix Metalloproteinase 9RatsNF-kappa BCytokinesAntioxidantsAnti-Inflammatory AgentsRats, WistarInflammationDisease Models, AnimalInflammation Mediators

Author keywords

colitisethyl pyruvaterattrinitrobenzene sulfonic acid

Substances

ethyl pyruvateTrinitrobenzenesulfonic AcidPyruvatesNitric Oxide Synthase Type IIMatrix Metalloproteinase 9NF-kappa BCytokinesAntioxidantsAnti-Inflammatory AgentsInflammation Mediators

Authors and institutions

  • Faculty of Medicine, Haliç University, Eyup, Istanbul, Turkey.
  • Department of Gastroenterology, University of Health Sciences, Bağcılar Training and Research Hospital, Istanbul, Turkey.
  • Department of Neuroscience, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
  • Departments of Biochemistry, Bağcılar Training and Research Hospital, Istanbul, Turkey.
  • Medical Oncology Clinic, University of Istanbul Medipol, Istanbul, Turkey.
  • Molecular Biology and Genetics, Haliç University, Istanbul, Turkey.

ORCID profiles: Hatice Yorulmaz, Elif Yorulmaz, Elif Özkök, Suat Hayri Küçük, Erdem Sünger, Ayyub Ebrahimi, Beyza Yılmaz, Serdar Altınay

Funding

  • Turkish Ministry of Health, Bağcılar Training and Research Hospital

Cite

APA

Yorulmaz, H., Yorulmaz, E., Özkök, E., Küçük, S. H., Sünger, E., Ebrahimi, A., Yılmaz, B., & Altınay, S. (2026). Timing‐dependent protective and therapeutic effects of ethyl pyruvate in trinitrobenzene sulfonic acid‐induced experimental colitis. Experimental Physiology, 111(8), 3731-3741. https://doi.org/10.1113/ep093786

Vancouver

Yorulmaz H, Yorulmaz E, Özkök E, Küçük SH, Sünger E, Ebrahimi A, et al. Timing‐dependent protective and therapeutic effects of ethyl pyruvate in trinitrobenzene sulfonic acid‐induced experimental colitis. Experimental Physiology. 2026;111(8):3731-3741. doi:10.1113/ep093786

BibTeX
@article{Yorulmaz2026,
  author = {Yorulmaz, Hatice and Yorulmaz, Elif and Özkök, Elif and Küçük, Suat Hayri and Sünger, Erdem and Ebrahimi, Ayyub and Yılmaz, Beyza and Altınay, Serdar},
  title = {Timing‐dependent protective and therapeutic effects of ethyl pyruvate in trinitrobenzene sulfonic acid‐induced experimental colitis},
  journal = {Experimental Physiology},
  year = {2026},
  volume = {111},
  number = {8},
  pages = {3731--3741},
  doi = {10.1113/ep093786}
}
Start for free →